Sort
64,565 grants matching “drug discovery”
Cancer Center Support Grant (CORE)
$1,165,054Timothy L Ratliff · Purdue University · P30 · FY2007 · CA
Tissue Processing-Sequencing Facility
$1,164,770Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Small Molecule Therapeutics for Botullinum Neurotoxin A
$1,164,173Tobin J Dickerson · Scripps Research Institute, The · U01 · FY2012 · AI
Medical Scientist Training Program
$1,164,113Christopher S. Williams · Vanderbilt University · T32 · FY2015 · GM
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder
$1,163,856Richard Joseph Johnson · Colorado Research Partners, Llc · U01 · FY2022 · AA
Target ID (3 of 4)
$1,163,676Stuart L Schreiber · Broad Institute, Inc. · RL1 · FY2009 · HG
Personalized Cystic Fibrosis Therapy and Research Center
$1,163,071Anjaparavanda P Naren · Cincinnati Childrens Hosp Med Ctr · P30 · FY2019 · DK
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,162,978Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2016 · CA
Systems Approach to Unraveling the Genetic Basis of Heart Failure
$1,162,645James N Weiss · University Of California Los Angeles · R01 · FY2013 · HL
Biased Agonism In GPCR Drug Discovery: Application To Somatostatin Agonists
$1,162,633Richard Scott Struthers · Crinetics Pharmaceuticals, Inc. · R44 · FY2014 · DK
Validation of HYPE as an Actionable Target for Alzheimer's Disease
$1,162,500Kavita Shah · Purdue University · RF1 · FY2022 · NS
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa
$1,162,415David Roy Bangsberg · Massachusetts General Hospital · R01 · FY2012 · MH
Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines
$1,162,409Christopher A. Gaiteri · Rush University Medical Center · R01 · FY2018 · AG
Nephrotic Syndrome Rare Disease Clinical Research Network
$1,162,153Matthias Kretzler · University Of Michigan At Ann Arbor · U54 · FY2015 · DK
The EcoCyc Model Organism Database for Escherichia coli
$1,162,075Peter D Karp · Sri International · R01 · FY2022 · GM
The EcoCyc Model Organism Database for Escherichia coli
$1,161,946Peter D Karp · Sri International · R01 · FY2021 · GM
The EcoCyc Model Organism Database for Escherichia coli
$1,161,946Peter D Karp · Sri International · R01 · FY2020 · GM
Center of Research Translation on the Osteoimmunology of Bone Infection
$1,161,631Edward M Schwarz · University Of Rochester · P50 · FY2020 · AR
Development of PEGylated MTI-101 for the treatment of relapsed Myeloma
$1,161,570Rikki Noel Waterhouse · Modulation Therapeutics, Inc. · R44 · FY2018 · CA
MIND Institute Intellectual and Developmental Disabilities Research Center
$1,161,491Judy A. Van De Water · University Of California At Davis · P50 · FY2025 · HD
Therapeutic Strategies to Augment Muscle Rehabilitation
$1,161,411Krista H Vandenborne · University Of Florida · P01 · FY2009 · HD
Immobilized Receptors In Drug Discovery
$1,161,344Irving William Wainer · Aging · Z01 · FY2007 · AG
Pre-Clinical Testing Core
$1,160,721Paul Richard Territo · Indiana University Indianapolis · U54 · FY2017 · AG
Pre-Clinical Testing Core
$1,160,721Paul Richard Territo · Indiana University Indianapolis · U54 · FY2019 · AG
Nipah & Hendra Virus Nonhuman Primate Model & Therapeutics Development
$1,160,710Thomas William Geisbert · University Of Texas Med Br Galveston · U01 · FY2011 · AI